MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFT · Real-Time Price · USD
2.020
+0.200 (10.99%)
At close: Jan 2, 2026, 4:00 PM EST
2.000
-0.020 (-0.99%)
After-hours: Jan 2, 2026, 7:38 PM EST
MindWalk Holdings Revenue
MindWalk Holdings had revenue of 4.12M CAD in the quarter ending October 31, 2025, with 53.94% growth. This brings the company's revenue in the last twelve months to 26.65M, up 49.46% year-over-year. In the fiscal year ending April 30, 2025, MindWalk Holdings had annual revenue of 24.52M with 0.01% growth.
Revenue (ttm)
26.65M CAD
Revenue Growth
+49.46%
P/S Ratio
4.53
Revenue / Employee
261,304 CAD
Employees
102
Market Cap
94.32M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 24.52M | 2.00K | 0.01% |
| Apr 30, 2024 | 24.52M | 3.85M | 18.65% |
| Apr 30, 2023 | 20.67M | 1.30M | 6.72% |
| Apr 30, 2022 | 19.36M | 1.45M | 8.11% |
| Apr 30, 2021 | 17.91M | 3.85M | 27.41% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
HYFT News
- 18 days ago - MindWalk Holdings Corp. (HYFT) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 19 days ago - MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline - Business Wire
- 26 days ago - MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025 - Business Wire
- 7 weeks ago - MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025 - Business Wire
- 2 months ago - MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy - Business Wire
- 2 months ago - MindWalk Holdings: Repositioned TechBio Platform With Early LensAI Proof Points - Seeking Alpha
- 2 months ago - MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion - Business Wire
- 3 months ago - MindWalk Holdings Corp. (HYFT) ImmunoPrecise Antibodies Ltd. - Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha